Literature DB >> 30354722

Bilirubin, a Cardiometabolic Signaling Molecule.

Terry D Hinds1, David E Stec2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30354722      PMCID： PMC6205727          DOI： 10.1161/HYPERTENSIONAHA.118.11130

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  92 in total

Review 1.  Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.

Authors:  Ai-Ching Boon; Andrew C Bulmer; Jeff S Coombes; Robert G Fassett
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-23

Review 2.  Cardiovascular Disease in Women: Clinical Perspectives.

Authors:  Mariana Garcia; Sharon L Mulvagh; C Noel Bairey Merz; Julie E Buring; JoAnn E Manson
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

Review 3.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

4.  The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus.

Authors:  Douwe Dekker; Mirrin J Dorresteijn; Margot Pijnenburg; Suzanne Heemskerk; Anja Rasing-Hoogveld; David M Burger; Frank A D T G Wagener; Paul Smits
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-18       Impact factor: 8.311

5.  Effects of fenofibrate on lipid metabolism in adipose tissue of rats.

Authors:  Adaliene Versiani Matos Ferreira; Gleydes Gambogi Parreira; Allan Green; Leida Maria Botion
Journal:  Metabolism       Date:  2006-06       Impact factor: 8.694

6.  High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy.

Authors:  Seung Seok Han; Ki Young Na; Dong-Wan Chae; Yon Su Kim; Suhnggwon Kim; Ho Jun Chin
Journal:  Tohoku J Exp Med       Date:  2010-06       Impact factor: 1.848

7.  Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid.

Authors:  R Stocker; E Peterhans
Journal:  Free Radic Res Commun       Date:  1989

8.  Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?

Authors:  Terry D Hinds; Samuel O Adeosun; Abdulhadi A Alamodi; David E Stec
Journal:  Med Hypotheses       Date:  2016-08-31       Impact factor: 1.538

Review 9.  PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?

Authors:  P L Feldman; M H Lambert; B R Henke
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

10.  Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C.

Authors:  Peter E M Gibbs; Cicerone Tudor; Mahin D Maines
Journal:  Front Pharmacol       Date:  2012-03-13       Impact factor: 5.810
View more
  26 in total

1.  Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.

Authors:  David E Stec; Darren M Gordon; Jennifer A Hipp; Stephen Hong; Zachary L Mitchell; Natalia R Franco; J Walker Robison; Christopher D Anderson; Donald F Stec; Terry D Hinds
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-04       Impact factor: 3.619

2.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

3.  RNA sequencing in human HepG2 hepatocytes reveals PPAR-α mediates transcriptome responsiveness of bilirubin.

Authors:  Darren M Gordon; Thomas M Blomquist; Scott A Miruzzi; Robert McCullumsmith; David E Stec; Terry D Hinds
Journal:  Physiol Genomics       Date:  2019-05-10       Impact factor: 3.107

Review 4.  Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health.

Authors:  Terry D Hinds; David E Stec
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

Review 5.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

Review 6.  Novel Function for Bilirubin as a Metabolic Signaling Molecule: Implications for Kidney Diseases.

Authors:  David E Stec; Claudio Tiribelli; Olufunto O Badmus; Terry D Hinds
Journal:  Kidney360       Date:  2022-03-25

7.  Serum Bilirubin Concentrations and the Prevalence of Gilbert Syndrome in Elite Athletes.

Authors:  Jana Woronyczová; Miroslava Nováková; Martin Leníček; Miloš Bátovský; Emil Bolek; Renata Cífková; Libor Vítek
Journal:  Sports Med Open       Date:  2022-06-27

Review 8.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

9.  Pharmacological and Clinical Significance of Heme Oxygenase-1.

Authors:  David E Stec; Nader G Abraham
Journal:  Antioxidants (Basel)       Date:  2021-05-27

10.  SERUM BILIRUBIN CORRELATES WITH SERUM ADIPOKINES IN NORMAL WEIGHT AND OVERWEIGHT ASYMPTOMATIC ADULTS.

Authors:  Ana Petelin; Mihaela Jurdana; Zala Jenko Pražnikar; Lovro Žiberna
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.932
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.